87 results
Page 2 of 5
8-K
EX-99.1
v9xvsfdvs7pzoqhoi sk
4 May 23
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
EX-99.1
16sk83etvflsv0i92zu
18 Apr 23
Regulation FD Disclosure
10:42am
8-K
EX-99.2
ad9x4pfepotp5 a2q38
18 Apr 23
Regulation FD Disclosure
10:42am
8-K
EX-99.1
ct50 wwln
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
8-K
EX-99.2
qna9rhb9pl94t
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
8-K
EX-99.1
cownlqblogvq jn53r8
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
424B5
bie1juj
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B5
hxjmuq
12 Sep 22
Prospectus supplement for primary offering
7:35am
8-K
EX-99.1
v4mbzohoqem1lmbzhb3
12 Sep 22
Enrollment for the pivotal cohort anticipated to be completed in the second half of 2023
6:05am
8-K
EX-99.2
rtnitudww0avw6ewsz
12 Sep 22
Enrollment for the pivotal cohort anticipated to be completed in the second half of 2023
6:05am
424B7
07q2f9y uzgtpi5gz
1 Sep 22
Prospectus with selling stockholder info
4:06pm
8-K
EX-99.1
xdhgqee cccd8
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
7cfpfguhu5c
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.2
bsywhmmg94wsqdk7f
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.1
23k90efgat46s9u
27 Jun 22
Regulation FD Disclosure
6:11am